Logo Lucerna-Chem
+41 41 420 9636

Regulatory Status

Article Status


CBR-470-1


Catalog Number Pack Size List Price* Promo Price* Quantity
HY-134205A-5MG 5 mg 573,00 487,10 Add
HY-134205A-10MMO 10 mM * 1 mL 630,00 535,50 Add
HY-134205A-10MG 10 mg 881,00 748,90 Add
HY-134205A-25MG 25 mg 1'705,00 1'449,30 Add
HY-134205A-50MG 50 mg 2'638,00 2'242,30 Add
HY-134205A-100MG 100 mg 3'848,00 3'270,80 Add

* CHF, excl. 7.7% VAT and shipping costs


Product Description

CBR-470-1 is an inhibitor of the glycolytic enzyme phosphoglycerate kinase 1 (PGK1). CBR-470-1 is also a non-covalent Nrf2 activator. CBR-470-1 protects SH-SY5Y neuronal cells against MPP+-induced cytotoxicity through activation of the Keap1-Nrf2 cascade.

Category Biochemicals
Supplier MedChem Express
Application Metabolism-protein/nucleotide metabolism
Regulatory Status RUO
Format Solubility: DMSO : 200 mg/mL (546.60 mM; Need ultrasonic)
Grade Clinical information: No Development Reported
Purity 98.35%
Molecular Formula C14H20ClNO4S2
Molecular Weight 365.9
CAS-Number [2416095-06-0]
Storage Conditions Powder -20°C 3 years, 4°C 2 years; In solvent -80°C 6 months, -20°C 1 month
Product Line Research
Tech. Data Sheet View datasheet
Link To Supplier http://www.medchemexpress.com
Material Safety Data Sheet Download PDF
Call us

Customer Support
T +41 41 420 96 36
F +41 41 420 96 56
info@lucerna-chem.ch

Business Hours
From Monday through Friday
08:00 – 12:00
13:00 – 17:00

Ask us

Technical Support
tech@lucerna-chem.ch

Business Development
business.dev@lucerna-chem.ch

Postal address
Lucerna-Chem AG
Abendweg 18
CH-6006 Luzern

Newsletter













If you have already subscribed to our newsletter and would like to update your details or cancel it, please click here.


© Copyright 2021 Lucerna-Chem AG, Switzerland